Real-time enrollment status for this chronic neutropenia clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 11:16 AM UTC
| NCT Number | NCT06056297 |
| Recruiting Status | Recruiting |
| Condition | Chronic Neutropenia |
| Phase | PHASE3 |
| Target Enrollment | 176 participants |
| Active Locations | 22 sites in the US |
| Sponsor | X4 Pharmaceuticals |
| Last Updated on CT.gov | August 6, 2026 (Aug 6, 2026) |
As of October 15, 2026: Clinical trial NCT06056297 is currently recruiting participants. This phase3 study for chronic neutropenia is actively seeking new participants at 22 locations across the United States. The study is sponsored by X4 Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06056297 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06056297 was last updated Aug 6, 2026 (August 6, 2026). HelloStudys verifies this status automatically.